Benefits of Microcor in Ambulatory Decompensated Heart Failure
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 265 participants.
Also called NCT04096040
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose diagnostic
- Phase
- Not applicable
- Enrolled
- 265 participants
- Sponsor
- Registry
-
NCT04096040
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States, Austria, France, Germany
- Registry status
- Completed
Technical summary
Registry record NCT04096040. Allocation not applicable; no masking; primary purpose diagnostic. Start 2019-11-01 (actual); primary completion 2023-06-30 (actual). Results posted on 2024-10-09.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Benefits of Microcor in Ambulatory Decompensated Heart Failure
- Acronym
- BMAD-TX
- Condition
- Heart Failure
- Intervention (Device)
- μCor
- Lead sponsor
- Zoll Medical Corporation
Record details
- Record id
cardio:ct-nct04096040- Content hash
38358277c8d1e34b73ceab91a750268e9ce7b3714e23086dded8f39ed805e058